Chia Tai Enterprises International (HKG:3839) expects an attributable profit of around $9.5 million for the six months ended June 30, down from $17 million a year prior.
The biochemical and industrial sector company attributed the forecast to a decline in the performance of its chlortetracycline and animal health businesses amid a slowdown in China's animal farming sector.